Search - tctmd.com

Displaying 261 - 280 of 1210

Sort: Relevancy | Date

Presentation NY Valves 2024

An Objective Measure of Pacemaker Slack Grade for Transcatheter Tricuspid Valve Intervention

Presenter: Craig Basman

June 05, 2024

Presentation NY Valves 2024

Risk Stratification for Aortic Regurgitation: Echo or CMR?

Presenter: Joao L. Cavalcante

June 05, 2024

Presentation NY Valves 2024

Outcomes of Tricuspid Transcatheter Edge-to-Edge Valve Repair in ESRD Patients

Presenter: Lamiya Rodriguez

June 05, 2024

Presentation NY Valves 2024

Immediate and Early Results of Bicaval Valve Implantation - TricValve - A Case Series

Presenter: Mohamad Said Ghandour

June 05, 2024

Presentation NY Valves 2024

Quantitation of Tricuspid Regurgitation by Cardiac Magnetic Resonance

Presenter: Davide Margonato

June 05, 2024

Presentation NY Valves 2024

Mitral Regurgitation Quantitation: Are Different Methods Required for Primary vs Secondary Disease?

Presenter: Paul A. Grayburn

June 05, 2024

Presentation NY Valves 2024

Exploring the Immediate Effects of Tricuspid Transcatheter Edge-to-Edge Repair on Biventricular Cardiomechanics

Presenter: Antoon van den Enden

June 05, 2024

Presentation NY Valves 2024

Impact of Tricuspid Transcatheter Edge to Edge Repair on Right Ventricular Function

Presenter: Parasuram Krishnamoorthy

June 05, 2024

Presentation NY Valves 2024

Transcatheter Aortic Valve Replacement Reduces Tricuspid Regurgitation Severity at 30 Days – Insights From a Large Academic Medical Center Study

Presenter: Shreeya Shabari

June 05, 2024

Presentation NY Valves 2024

Progression of Mitral Regurgitation Severity After Transcatheter Tricuspid Valve Replacement

Presenter: Melissa Yen Yen Moey

June 05, 2024

News Conference News EuroPCR 2024

Young, Low-risk Patients Fare Well With TAVI, but Beware the Bicuspids

Michael O'Riordan

May 15, 2024

News Conference News EuroPCR 2024

Myval Matches Contemporary TAVI at 30 Days, but Do More Sizes Matter?

Shelley Wood

May 15, 2024

News Conference News EuroPCR 2024

Debate Continues on TAVI Choice for Women With Small Annuli

Yael L. Maxwell

May 14, 2024

News Daily News

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

Michael O'Riordan

May 07, 2024

News Daily News

STS Releases New Risk-Prediction Tools for Emerging Surgical Scenarios

Yael L. Maxwell

May 01, 2024

Another Win for TAVI in Low-to-Intermediate Risk Patients

News Conference News ACC 2024

Another Win for TAVI in Patients at Low-to-Intermediate Risk: DEDICATE-DZHK6

Yael L. Maxwell

April 08, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for March 2024

Shelley Wood

April 03, 2024

News Daily News

FDA Approves TriClip TEER Device for Tricuspid Repair

L.A. McKeown

April 02, 2024

News Opinion CV Team Dispatch

April 2024 Dispatch for the CV Team

L.A. McKeown

April 01, 2024

News Opinion Off Script

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Sanjay Kaul, MD

March 29, 2024

Advertisement

An Objective Measure of Pacemaker Slack Grade for Transcatheter Tricuspid Valve Intervention

Risk Stratification for Aortic Regurgitation: Echo or CMR?

Outcomes of Tricuspid Transcatheter Edge-to-Edge Valve Repair in ESRD Patients

Immediate and Early Results of Bicaval Valve Implantation - TricValve - A Case Series

Quantitation of Tricuspid Regurgitation by Cardiac Magnetic Resonance

Mitral Regurgitation Quantitation: Are Different Methods Required for Primary vs Secondary Disease?

Exploring the Immediate Effects of Tricuspid Transcatheter Edge-to-Edge Repair on Biventricular Cardiomechanics

Impact of Tricuspid Transcatheter Edge to Edge Repair on Right Ventricular Function

Transcatheter Aortic Valve Replacement Reduces Tricuspid Regurgitation Severity at 30 Days – Insights From a Large Academic Medical Center Study

Progression of Mitral Regurgitation Severity After Transcatheter Tricuspid Valve Replacement

Young, Low-risk Patients Fare Well With TAVI, but Beware the Bicuspids

Myval Matches Contemporary TAVI at 30 Days, but Do More Sizes Matter?

Debate Continues on TAVI Choice for Women With Small Annuli

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

STS Releases New Risk-Prediction Tools for Emerging Surgical Scenarios

Another Win for TAVI in Patients at Low-to-Intermediate Risk: DEDICATE-DZHK6

TCTMD’s Top 10 Most Popular Stories for March 2024

FDA Approves TriClip TEER Device for Tricuspid Repair

April 2024 Dispatch for the CV Team

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content